Direct to Patient Trials (WS4)

With an increase in the number of worldwide studies and with more clinical protocols involving biologics coupled with the increased pressure to recruit and retain patients in addition to optimizing patient compliance, new and innovative ways need to be found to customize IMP closer to the patient as well as supporting the delivery of clinical supplies to patients homes.  This workshop will discuss summarize the benefits and risks as well as practical approaches to implementing strategies to support these concepts.